Eylea is forecast to attain revenues of US$4,475 million and overtake Lucentis revenues by 2022
A new report produced by a business and market research company (Vertical Edge Limited, London, UK) has predicted that sales of Regeneron’s Eylea (aflibercept) will… Read More »Eylea is forecast to attain revenues of US$4,475 million and overtake Lucentis revenues by 2022